May 16, 2023 / 08:05PM GMT
Gregory James Renza - RBC Capital Markets, Research Division - Analyst
Welcome to the 2023 RBC Global Healthcare Conference. My name is Greg Renza, one of the senior biotech equity research analysts here at RBC. And we're pleased to be joined by Jazz Pharmaceuticals, and with a robust team today, led by the Chairman and CEO, Bruce Cozadd.
Bruce, Rob, P.J., Abizer, it's great to have you.
Bruce, I'll turn it over to you for an intro, not just to Jazz, but also to the great team you have here today.
Bruce C. Cozadd - Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO
Yes. So I'm Bruce Cozadd, Chairman and CEO, Founder of Jazz Pharmaceuticals. Good to see you all today. Pleased to be joined by some fellow members of the management team.
It doesn't look like our management team is half diverse because we just brought the guys this time, but I want you to know half -- more than half of our management team is diverse by gender, color, or LGBTQ status.
We've got with us today, starting next to me, P.J. Honerkamp. P.J. runs
Jazz Pharmaceuticals PLC at RBC Capital Markets Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
